121 related articles for article (PubMed ID: 10855461)
1. A prospective PMS study to validate the sensitivity for change of the D-scale in advanced stages of dementia using the NMDA-antagonist memantine.
Rüther E; Glaser A; Bleich S; Degner D; Wiltfang J
Pharmacopsychiatry; 2000 May; 33(3):103-8. PubMed ID: 10855461
[TBL] [Abstract][Full Text] [Related]
2. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
Görtelmeyer R; Erbler H
Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
[TBL] [Abstract][Full Text] [Related]
3. Memantine (Ebixa) in clinical practice - results of an observational study.
Calabrese P; Essner U; Forstl H
Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
[TBL] [Abstract][Full Text] [Related]
4. Memantine in moderate-to-severe Alzheimer's disease.
Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ;
N Engl J Med; 2003 Apr; 348(14):1333-41. PubMed ID: 12672860
[TBL] [Abstract][Full Text] [Related]
5. Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.
Schulz JB; Rainer M; Klünemann HH; Kurz A; Wolf S; Sternberg K; Tennigkeit F
J Alzheimers Dis; 2011; 25(3):463-75. PubMed ID: 21471647
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
Ditzler K
Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796
[TBL] [Abstract][Full Text] [Related]
7. Memantine enhances autonomy in moderate to severe Alzheimer's disease.
Rive B; Vercelletto M; Damier FD; Cochran J; François C
Int J Geriatr Psychiatry; 2004 May; 19(5):458-64. PubMed ID: 15156547
[TBL] [Abstract][Full Text] [Related]
8. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial.
Pomara N; Ott BR; Peskind E; Resnick EM
Alzheimer Dis Assoc Disord; 2007; 21(1):60-4. PubMed ID: 17334274
[TBL] [Abstract][Full Text] [Related]
9. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
10. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.
Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ
Arch Neurol; 2006 Jan; 63(1):49-54. PubMed ID: 16401736
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
12. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
13. [Advanced dementia in Alzheimer's disease and memantine].
Alberca R
Rev Neurol; 2005 Feb 1-15; 40(3):173-9. PubMed ID: 15750904
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
15. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
Keck PE; Hsu HA; Papadakis K; Russo J
Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
17. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
Hartmann S; Möbius HJ
Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
